Benefits
Traditional adaptogenic use
Extensive traditional use across Amazonian and cerrado regions of Brazil as anti-stress agent, tonic, aphrodisiac, and memory enhancer. Folk medicine heritage supports broad multi-indication use, though modern clinical evidence for these specific indications remains limited.
Intestinal anti-inflammatory effects (preclinical)
Rat studies in TNBS-induced intestinal inflammation show that Pfaffia paniculata extract significantly decreased macroscopic damage scores, lesion extension, and colonic myeloperoxidase activity. Preclinical evidence for inflammatory bowel applications — human translation has not been demonstrated.
MAPK and mucin pathway modulation
Follow-up mechanistic work shows Pfaffia modulates MAPK and mucin pathways in intestinal inflammation models. Provides mechanistic rationale for the anti-inflammatory observations in rat models. All preclinical evidence — no human trial validation.
Chemopreventive signals (preclinical)
Mouse hepatocarcinogenesis model showed inhibitory effects on preneoplastic and neoplastic lesions. Additional preclinical signals include reduced corneal angiogenesis and cytotoxic effects on breast cancer cell lines. Promising preclinical chemoprevention but no human cancer trials.
β-Ecdysterone and saponin actives
β-ecdysterone is a phytosteroid with anabolic and adaptogenic activity, studied separately for osteogenic effects and chondrocyte inflammation reduction via NF-κB inhibition. The most distinguishing bioactive class for Pfaffia among adaptogens.
Antinociceptive effects (preclinical)
Mouse pain model studies show antinociceptive effects through glutamate and cytokine pathways. Preclinical mechanism supporting traditional pain-relief use — clinical pain translation has not been demonstrated.
Honest limitation — weak human evidence
Studies on Pfaffia are scarce compared to well-documented adaptogens like Panax ginseng, Eleutherococcus, and Withania (ashwagandha). Most evidence is preclinical. WebMD and similar evidence reviews note insufficient scientific evidence for cancer, diabetes, sexual performance, or immune claims.
Mechanism of action
β-Ecdysterone phytosteroid anabolic and adaptogenic
β-ecdysterone is the distinguishing bioactive — a phytosteroid with anabolic, osteogenic, and adaptogenic activity. ER-β binding has been reported. Mechanism is distinct from the saponin-based adaptogens (Panax, Eleutherococcus).
MAPK and mucin pathway intestinal regulation
Costa 2018 mechanism — modulates MAPK signaling and mucin production pathways in intestinal models. Mechanistic basis for the anti-inflammatory effects in the TNBS model.
NF-κB and MMP-9 inhibition (β-ecdysterone)
β-ecdysterone inhibits NF-κB signaling and MMP-9 expression — broad anti-inflammatory mechanism with implications for joint inflammation, IBD, and cancer cell invasion.
Antinociceptive glutamate and cytokine modulation
Freitas 2009 — antinociceptive effects via glutamate receptor and cytokine pathway modulation. Preclinical pain mechanism distinct from opioid or NSAID pathways.
Macrophage activity enhancement
Matsuzaki 2003 — 200 mg/kg reduced Ehrlich ascitic tumor volume via increased macrophage activity. Innate immune activation as a proposed antitumor mechanism.
HPA axis adaptogen multi-target
Traditional adaptogen positioning suggests HPA axis modulation, though dedicated mechanistic work on Pfaffia HPA axis effects is limited. Adaptogen claims rest more on traditional use than on modern HPA-axis pharmacology.
Clinical trials
Clinical evidence on Pfaffia paniculata / Hebanthe eriantha (Brazilian Ginseng / Suma) for the indications and outcomes described.
Clinical population described in trial publication.
Costa C et al. 2015 (Int Immunopharmacol 28:459-469, UNESP Botucatu PhytoPharmaTech). TNBS-induced intestinal inflammation rat study. 200 mg/kg significantly decreased macroscopic damage score, lesion extension, and colonic MPO activity. 25 mg/kg decreased Hsp70. Foundational preclinical anti-inflammatory evidence.
Clinical evidence on Pfaffia paniculata / Hebanthe eriantha (Brazilian Ginseng / Suma) for the indications and outcomes described.
Clinical population described in trial publication.
Cancer, 226:107-113. P. paniculata roots showed inhibitory effects on preneoplastic and neoplastic lesions in mouse hepatocarcinogenesis. Supportive preclinical work: — corneal angiogenesis reduction in rats. — MCF-7 breast cancer cell cytotoxicity. Preclinical chemoprevention signals; human cancer translation not established.
Clinical evidence on Pfaffia paniculata / Hebanthe eriantha (Brazilian Ginseng / Suma) for the indications and outcomes described.
Clinical population described in trial publication.
Freitas C et al. 2009 (J Ethnopharmacol 122:468-472). Antinociceptive effects in mouse models via glutamate and cytokine pathway modulation. Preclinical mechanism for traditional pain-relief use.